View Section: Company Analysis
NewAmsterdam Pharma Rating
NA
NAMS stock is not rated by Eyestock analysis.
The financial statements data is not enough to calculate the rating
Discover High-rated Companies
View Section: Valuation
NA
Last reporting period 31 Dec, 2022
Updated 18 Nov, 2024
Last price
—
Market cap $B
0.174
Exchange
XNAS - Nasdaq
NA
NAMS stock is not rated by Eyestock analysis.
The financial statements data is not enough to calculate the rating